Skip to main content
Ondine Biomedical Inc. logo

Ondine Biomedical Inc. — Investor Relations & Filings

Ticker · OBI ISIN · CA68234M2058 LEI · 9845005B69E07CGF4A56 TSXV Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2026-05-28 Report Publication Anno…
Country CA Canada
Listing TSXV OBI

About Ondine Biomedical Inc.

https://ondinebio.com/

Ondine Biomedical Inc. is a life sciences company that develops and commercializes photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by drug-resistant pathogens. The company's patented platform technology involves applying a photosensitive agent to a targeted area, followed by illumination with non-thermal laser light. This process creates an oxidative burst that rapidly destroys pathogens like bacteria, viruses, and fungi without inducing microbial resistance. Its lead product, Steriwave™, is a nasal decolonization therapy used to eradicate pathogens in the nasal cavity, primarily to reduce the risk of healthcare-associated infections (HAIs) such as post-operative surgical site infections. The company's product pipeline is exploring applications for chronic rhinosinusitis, burns, wounds, and ventilator-associated pneumonia.

Recent filings

Filing Released Lang Actions
Notice of Results and Investor Presentation
Report Publication Announcement Classification · 90% confidence The document is an RNS announcement stating that audited full year results and the Annual Report for the year ended 31 December 2025 will be published on 4 June 2026, and details an upcoming investor presentation and live Q&A. It contains no actual financial data, only timing and publication details. This matches the definition of a Report Publication Announcement (RPA).
2026-05-28 English
Steriwave ICU Study Outcomes Presented at CSRT2026
Regulatory Filings Classification · 78% confidence The document is a press release from the London Stock Exchange’s Regulatory News Service (RNS) announcing the presentation of a clinical feasibility study at a medical conference. It does not contain financial results, vote outcomes, board changes, or substantive financial statements. It is a general regulatory announcement, fitting the fallback category.
2026-05-26 English
Notification of major holdings - hInsight-NX, LLC
Major Shareholding Notification Classification · 100% confidence The document is a TR-1 form notification of major holdings, which is a regulatory filing used to disclose significant share ownership changes. It includes details such as the issuer's name, the shareholder's name, the percentage of voting rights held, and the date the threshold was crossed. The document is structured as a formal notification to the Financial Conduct Authority (FCA) and the issuer, consistent with major shareholding notifications. There is no financial performance data, management discussion, or other report content. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is not a brief announcement or a report publication notice but the actual notification form.
2026-05-06 English
Notification of major holdings - Carolyn Cross
Major Shareholding Notification Classification · 100% confidence The document is a TR-1 form notification of major holdings, which is a regulatory filing used to disclose when a shareholder crosses a threshold of voting rights in a company. It includes details such as the identity of the issuer, the shareholder, the percentage of voting rights held, and the date the threshold was crossed. The document is not a financial report, earnings release, or management discussion, but a formal notification of shareholding changes. This fits the definition of Major Shareholding Notification (MRQ). The document length and content confirm it is the notification itself, not an announcement or summary. Therefore, the correct classification is MRQ with high confidence.
2026-05-06 English
Notification of major holdings - Pentwater
Major Shareholding Notification Classification · 100% confidence The document is a standard form notification of major holdings for Ondine Biomedical Inc., indicating a change in share ownership percentages and financial instruments held by Pentwater Capital Management LP. It includes details such as the date the threshold was crossed, percentage of shares held, and related information. This type of document is a notification of changes in significant share ownership levels, which fits the definition of Major Shareholding Notification (MRQ). The document is not a full financial report, earnings release, or any other type of report but a regulatory announcement about shareholding changes.
2026-05-05 English
Ondine Presented Steriwave Data at IPC 2026
Regulatory Filings Classification · 95% confidence The document is a press release announcing Ondine Biomedical's presentation of Steriwave data at a recent Infection Prevention and Control Conference. It discusses the content of the presentation, clinical and economic impacts, and company information. There are no financial statements, regulatory filings, or detailed financial results. The document is an announcement of a corporate event and product information rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a general corporate announcement related to product and conference participation, which aligns best with the Regulatory Filings (RNS) category as a general announcement that does not fit other specific categories.
2026-04-30 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.